Applications Now Open for Pioneering Digital Health Accelerator Programme

The Yorkshire & Humber AHSN (Academic Health Science Network), in partnership with mHabitat, announces that applications for the 2019 Propel@YH digital health accelerator programme are now open. Propel@YH has been launched to provide innovative organisations developing digital health solutions with access to a structured course of support and advice aimed at helping its business cohort to navigate the NHS, whilst enabling accelerated company growth and increased market presence.

The programme is open to all SMEs that can demonstrate innovative digital and patient solutions and have either an existing presence in the Yorkshire and Humber region or are willing to establish one.

It will provide a unique and tailored set of advisory, guidance and support services to enable global organisations to bring innovative digital health and patient solutions to the region’s population and the wider health economy.

Six organisations will be chosen to take part in a six-month programme of masterclasses, digital innovator surgeries and events focused on human-related design, clinical safety by design and understanding NHS procurement.

They will also have access to expert partners – including NHS providers and commissioners, academic institutions, primary and secondary care organisations - and receive expert mentorship and dedicated one-to-one support on topics including marketing, law and finance. In addition, patient representatives will be involved in helping the cohort to develop a patient-centred, co-designed approach to their work.

Meanwhile, a further six organisations will receive an associate support package, including access to selected courses and sessions.

The accelerator programme, which will be based in Leeds, has been commissioned by Yorkshire & Humber AHSN and will be delivered by mHabitat, an NHS-owned co-design specialist and expert in the application of digital to health and care.

Richard Stubbs, Chief Executive for the Yorkshire & Humber AHSN said: "I am delighted to announce that applications are now being accepted by Propel@YH for its inaugural accelerator programme. We’re looking forward to hearing from digital health innovators that would like to find out how our access tailored support, guidance and advice in navigating the NHS can benefit their businesses.

"The NHS Long Term Plan announced last week re-established the importance of using state-of-the-art technological advances to improve outcomes for patients and the need to speed up the digital innovation pipeline to help to sustain the NHS for the future.

"The Yorkshire and Humber region is a hotbed of digital innovation and an ideal place to start and grow a business; where entrepreneurial innovators are not only leading the way in digital healthcare technology, they're also generating economic growth and creating employment opportunities”.

Digital health innovators may apply for a place on Propel@YH via www.propel-yh.com until applications close on Thursday, 28 February.

About Propel@YH

The Yorkshire & Humber AHSN (Academic Health Science Network), in partnership with mHabitat, will start delivery of Propel@YH from January 2019.

Propel@YH will become Yorkshire and Humber’s first regional digital health accelerator and will support organisations from across the world to bring their innovative digital health solutions to the region's patients and the wider health economy.

Propel@YH will provide a unique and tailored set of advisory, guidance and supportive services, enabling digital health solutions to flourish within the region.

Recognising that the sales cycle within healthcare can be challenging and often lengthy, Propel@YH will provide a structured programme of support and advice that will enable organisations to accelerate their growth and market presence in the longer term.

About Yorkshire & Humber Academic Health Science Network

Yorkshire & Humber AHSN is one of 15 AHSNs set up by NHS England in 2013 and relicensed from April 2018 to operate as the key innovation arm of the NHS.

The aim of the Yorkshire & Humber AHSN is to create significant improvements in the health of the population by reducing service variability and improving patient experience in the health care system.

The Yorkshire & Humber AHSN helps ensure new innovative products and services that have the potential to transform lives become part of routine clinical practice. The organisation also assists in providing economic growth for the region, supporting inward investment projects and industry that support the health sector.

The Yorkshire & Humber AHSN is the commissioning organisation behind Propel@YH and has funded the programme.

About mHabitat

Hosted by Leeds and York Partnership NHS Foundation Trust, mHabitat supports people-centred digital innovation in health and social care. We have a social purpose — to develop digital technologies for good that address real world problems.

At the core of everything we do, is co-design with patients, citizens and practitioners. mHabitat works with providers and commissioners of health and care services, third and public sector, digital innovators and health tech companies, academic organisations, and national bodies such as NHS England and NHS Digital. We help our partners collaborate and innovate for social good. We run digital innovation and inclusion projects, programmes and accelerators as well as advising on policy and strategy.

mHabitat has been commissioned by the Yorkshire & Humber AHSN to lead the delivery of the Propel@YH Digital Health Accelerator.

Most Popular Now

Almirall Takes a Leap into Dermatology D…

Almirall, S.A. (ALM) has launched its first call for innovation to start-ups focused on dermatology digital health. This initiative is the first step in the creation of an accelerator programme...

The Bristol-Myers Squibb-Pfizer Alliance…

The Bristol-Myers Squibb-Pfizer Alliance and Fitbit announced at the TIME 100 Health Summit in New York that they are working together to help drive timely diagnosis of atrial fibrillation (AFib)...

Philips and Spencer Health Solutions Exp…

Building on their successful partnership providing medication adherence solutions to high-acuity patients in the U.S. Royal Philips (NYSE:PHG, AEX:PHIA), a global leader in health technology, and Spencer Health Solutions announced...

Using Artificial Intelligence to Predict…

Thyroid nodules are small lumps that form within the thyroid gland and are quite common in the general population, with a prevalence as high as 67%. The great majority of...

Bayer Launches LifeHub UK Focused on Art…

Bayer launched LifeHub UK to accelerate and optimize disease detection and data-driven drug discovery by developing artificial-intelligence-enabled imaging solutions. The new hub is the seventh pillar of Bayer's global network...

AI could Offer Warnings about Serious Si…

The more medications a patient takes, the greater the likelihood that interactions between those drugs could trigger negative side effects, including long-term organ damage and even death. Now, researchers at...

NHS Health Tech Team of the Year Named

A pioneering NHS trust has been recognised at the 2019 HTN Awards for its innovative work using InterSystems technology to help enhance care for hundreds of thousands of patients. North...

Philips and Klinikum Stuttgart Hospital …

Royal Philips (NYSE:PHG, AEX:PHIA), a global leader in health technology, and German Klinikum Stuttgart hospital, the largest provider in the region, announced they have signed a comprehensive 10-year innovation partnership...

Heartbeat Labs Hired Babylon Health's Ch…

The Berlin-based digital health platform Heartbeat Labs hired Chad Jennings as Chief Product Officer (CPO). Chad is a product and design leader with twenty years of experience at the intersection...

Combination of AI & Radiologists mor…

An artificial intelligence (AI) tool - trained on roughly a million screening mammography images - identified breast cancer with approximately 90 percent accuracy when combined with analysis by radiologists, a...

Abbott and Omada Health Partner to Offer…

Abbott (NYSE: ABT) and Omada Health announced today they are partnering to integrate Abbott's revolutionary FreeStyle Libre system, a continuous glucose monitoring (CGM) technology, with Omada Health's pioneering digital care...

First Entirely Digital Clinical Trial En…

As little as a daily ping on your phone can boost physical activity, researchers from the Stanford University School of Medicine and their collaborators report in a new study. The...